These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 21117302

  • 1. [Androgen and 17-hydroxyprogesterone concentrations in blood serum versus menstrual patterns in women with polycystic ovary syndrome (PCOS)].
    Rudnicka E, Kunicki M, Radowicki S.
    Ginekol Pol; 2010 Oct; 81(10):745-9. PubMed ID: 21117302
    [Abstract] [Full Text] [Related]

  • 2. A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17alpha enzyme activity in women with polycystic ovary syndrome.
    Colak R, Keleştimur F, Unlühizarci K, Bayram F, Sahin Y, Tutuş A.
    Eur J Endocrinol; 2002 Oct; 147(4):473-7. PubMed ID: 12370108
    [Abstract] [Full Text] [Related]

  • 3. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC, Rizos D, Valsamakis G, Deligeoroglou E, Grigoriou O, Chrousos GP, Creatsas G, Mastorakos G.
    J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
    [Abstract] [Full Text] [Related]

  • 4. Atorvastatin therapy decreases androstenedione and dehydroepiandrosterone sulphate concentrations in patients with polycystic ovary syndrome: randomized controlled study.
    Sathyapalan T, Smith KA, Coady AM, Kilpatrick ES, Atkin SL.
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):80-5. PubMed ID: 21972424
    [Abstract] [Full Text] [Related]

  • 5. Clinical observations and hormone screenings of patients with non-standard hypertrophy of the adrenal cortex.
    Franik G, Skałba P.
    Endokrynol Pol; 2011 Jan; 62(3):230-7. PubMed ID: 21717405
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Patterns of hormonal response to the GnRH agonist leuprolide in brothers of women with polycystic ovary syndrome: a pilot study.
    Petermann TS, Cartes A, Maliqueo M, Vantman D, Gutiérrez C, Toloza H, Echiburú B, Recabarren SE.
    Hum Reprod; 2004 Dec; 19(12):2742-7. PubMed ID: 15358722
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).
    Lewandowski KC, Cajdler-Łuba A, Salata I, Bieńkiewicz M, Lewiński A.
    Endokrynol Pol; 2011 Dec; 62(2):120-8. PubMed ID: 21528473
    [Abstract] [Full Text] [Related]

  • 10. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
    Pasquali R, Patton L, Pocognoli P, Cognigni GE, Gambineri A.
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
    [Abstract] [Full Text] [Related]

  • 11. Adrenal androgenic response to 2-hour ACTH stimulation test in women with PCOS.
    Erel CT, Senturk LM, Oral E, Colgar U, Ertungealp E.
    Gynecol Endocrinol; 1998 Aug; 12(4):223-9. PubMed ID: 9798131
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
    Adams JM, Taylor AE, Crowley WF, Hall JE.
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment.
    Suikkari AM, MacLachlan V, Montalto J, Calderon I, Healy DL, McLachlan RI.
    Hum Reprod; 1995 Mar; 10(3):513-9. PubMed ID: 7782424
    [Abstract] [Full Text] [Related]

  • 17. Ovarian influence on adrenal androgen secretion in polycystic ovary syndrome.
    Fruzzetti F, De Lorenzo D, Ricci C, Teti G.
    Fertil Steril; 1995 Apr; 63(4):734-41. PubMed ID: 7890056
    [Abstract] [Full Text] [Related]

  • 18. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013 Apr; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

  • 19. Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys.
    Abbott DH, Rayome BH, Dumesic DA, Lewis KC, Edwards AK, Wallen K, Wilson ME, Appt SE, Levine JE.
    Hum Reprod; 2017 Apr 01; 32(4):923-936. PubMed ID: 28333238
    [Abstract] [Full Text] [Related]

  • 20. Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome.
    Lerchbaum E, Schwetz V, Giuliani A, Pieber TR, Obermayer-Pietsch B.
    Fertil Steril; 2012 Nov 01; 98(5):1318-25.e1. PubMed ID: 22835450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.